In recognition of outstanding scholarship by early-career researchers studying at Hamad Bin Khalifa University (HBKU), Anjud Khamis N al-Mohannadi, a PhD student in the Biological and Biomedical Sciences programme at the College of Health and Life Sciences (CHLS), has been named by Sidra Medicine as the “Top Research Specialist Author of 2022”.
Al-Mohannadi, now a researcher at Sidra Medicine, received the award in recognition of a fact-finding analysis she co-authored and presented at the European Society of Gene and Cell Therapy Congress, held in Edinburgh from October 11 to 14. The paper was recently accepted for publication in the journal Blood Advances, by the American Society of Hematology.
Entitled “CD14+/CD31+ Monocytes expanded by UM171 correct Hemophilia A in zebrafish upon lentiviral gene transfer of factor VIII”, the collaborative study with scientists from Sidra Medicine and leading US and Italy-based institutions, is set to be of broad interest to hematologists and researchers striving to advance knowledge and permanent treatments for patients with Hemophilia A.
Acknowledging al-Mohannadi’s accomplishment, Dr Georges Nemer, interim dean of CHLS, said: “It is a great honour for CHLS, HBKU to continue attracting exceptional research talent to our multidisciplinary graduate programmes and to nurture future leaders. The achievements of our students and the consummation of our efforts to advance scientific work and translational healthcare research in applied areas of the biomedical sciences, as well as genomics, precision medicine, and exercise science, have proven of incredible value.”
Al-Mohannadi added: “I’m indebted to CHLS faculty and HBKU for the support they extend to early-career researchers, both through a rigorous curriculum and in developing our vital skills.”
Anjud Khamis N al-Mohannadi
